Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-06 14:06:08 ET
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call November 6, 2025 7:30 AM EST
Company Participants
Fabrice Chouraqui - CEO & Executive Director
Stephen Toor - Chief Commercial Officer & GM Americas
Anurag Relan - Chief Medical Officer
Kenneth Lynard - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript
Pharming Group N.V.
NASDAQ: PHAR
PHAR Trading
-4.44% G/L:
$15.18 Last:
10,294 Volume:
$15.13 Open:
PHAR Latest News
PHAR Stock Data
$1,106,258,522
65,794,170
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
